AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (6.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Case Report | Open Access

Intracranial hemorrhage and Covid-19: A retrospective analysis of 1675 hospitalized Covid-19 Brazilian patients

Artur Eduardo Martio( )Pedro de Moraes Rêgo SoaresOctávio Ruschel KaramWagner Lazaretto PaduaLuciano Bambini ManzatoPaulo Moacir Mesquita Filho
Neurosurgery Department, Hospital de Clínicas de Passo Fundo, Passo Fundo, Brazil
Show Author Information

Abstract

Objective

The present study seeks to overcome the lack of data on Covid-19 associated intracranial hemorrhage (ICH) in Brazil.

Methods

This is a retrospective, single-center case series of consecutive patients. It is a subanalysis of a larger study still in progress, which covers all neurological manifestations that occurred in patients admitted between March 1st, 2020 and June 1st, 2022, with active SARS-CoV-2 infection confirmed by polymerase chain reaction test. All patients with non-traumatic ICH were included.

Results

A total of 1675 patients were evaluated: 917 (54.75 %) had one or more neurological symptoms and 19 had non-traumatic ICH, comprising an incidence of 1.13 %. All patients had one or more risk factors for ICH. The presence of neurological manifestations before the ICH and ICU admission showed a statistically significant relationship with the occurrence of ICH (X2 = 6.734, p = 0.0095; OR = 4.47; CI = 1.3–15.4; and FET = 9.13; p = < 0.001; OR = 9.15; CI = 3.27–25.5 respectively).

Conclusion

Our findings were largely congruent with the world literature. We believe that the assessment of risk factors can accurately predict the subgroup of patients at increased risk of ICH, but further studies are needed to confirm these hypotheses.

References

1

Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci. 2022;21(3):77.

2

Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, Rodríguez-Gutiérrez R. Acute cerebrovascular events in severe and nonsevere COVID-19 patients: a systematic review and meta-analysis. Rev Neurosci. 2022;33(6):631-639.

3

Daly SR, Nguyen AV, Zhang Y, Feng D, Huang JH. The relationship between COVID-19 infection and intracranial hemorrhage: a systematic review. Brain Hemorrhages. 2021;2(4):141-150.

4

Sojka M, Drelich-Zbroja A, Kuczyńska M, et al. Ischemic and hemorrhagic cerebrovascular events related to COVID-19 coagulopathy and hypoxemia. Int J Environ Res Public Health. 2022;19(18):11823.

5

Jamora RDG, Prado MB, Anlacan VMM, Sy MCC, Espiritu AI. Incidence and risk factors for stroke in patients with COVID-19 in the Philippines: an analysis of 10,881 cases. J Stroke Cerebrovasc Dis. 2022;31(11):106776.

6

Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. Intracerebral hemorrhage in COVID-19: A narrative review. J Clin Neurosci. 2021;89:271-278.

7
Cates J. Risk for In-Hospital Complications Associated with COVID-19 andInfluenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020. MMWR Morbidity and Mortality Weekly Report. 2020;69.
8

Mishra S, Choueka M, Wang Q, et al. Intracranial hemorrhage in COVID-19 patients. J Stroke Cerebrovasc Dis. 2021;30(4):105603.

9

Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients. Chest. 2011;139(1):69-79.

10

Lechler E, Schramm W, Flosbach CW. The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). Pathophysiol Haemost Thromb. 1996;26(Suppl. 2):49-56.

11

Kleber FX, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J. 2003;145(4):614-621.

12

Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332(7537):325-329.

13

De A, Roy P, Garg VK, Pandey NK. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinol. 2010;21(1):57-61.

14
Cho SM, Premraj L, Fanning J, et al. Ischemic and hemorrhagic stroke among critically ill patients with coronavirus disease 2019. Critical Care Med. 2021;
15

Mitra J, Kodavati M, Provasek VE, et al. SARS-CoV-2 and the central nervous system: emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations. Ageing Res Rev. 2022;80:101687.

16

Shchukin IA, Fidler MS, Koltsov IA, Suvorov AY. COVID-19-associated stroke. Neurosci Behav Physiol. 2022;52(5):649-656.

17

Deana C, Bagatto D. Severe stroke in patients admitted to intensive care unit after COVID-19 infection: pictorial essay of a case series. Brain Hemorrhages. 2021.

18

Martínez-Salazar B, Holwerda M, Stüdle C, et al. COVID-19 and the vasculature: current aspects and long-term consequences. Front Cell Dev Biol. 2022;10:824851.

Brain Hemorrhages
Pages 57-64
Cite this article:
Martio AE, Soares PdMR, Karam OR, et al. Intracranial hemorrhage and Covid-19: A retrospective analysis of 1675 hospitalized Covid-19 Brazilian patients. Brain Hemorrhages, 2023, 4(2): 57-64. https://doi.org/10.1016/j.hest.2023.01.002

112

Views

0

Downloads

2

Crossref

2

Web of Science

1

Scopus

Altmetrics

Received: 23 December 2022
Revised: 10 January 2023
Accepted: 16 January 2023
Published: 19 January 2023
© 2023 International Hemorrhagic Stroke Association.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return